Biotech

All Articles

Former Seagen CEO introduces brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was sold to Pfizer in 2015 for an immense $...

Ironwood makes further bid for $1B GI drug along with new subgroup data

.On the heels of a period 3 win that fell short to blow away entrepreneurs, Ironwood Pharmaceuticals...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Do not cease Monte Rosa Rehabs currently. The Boston-based biotech is having a ball after authorizi...

Jade carves out director crew with Chinook vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant management hirings, firings a...

Septerna goes public along with upsized offering of $288M

.Commemorating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer...

AbbVie creates Richter wealthier, spending $25M to make up finding treaty

.AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another bloc...

GenSight goes into last weeks of cash money path as income flow squeezes by of range

.GenSight Biologics is full weeks far from lacking money. Once more. The biotech only possesses adeq...

AZ licenses thrown out uncommon illness medication to Monopar Therapies

.Monopar Therapies is recovering a medication coming from the dump of AstraZeneca's rare ailment pip...

Arcus' brand-new HIF-2a information in kidney cancer cells hint at prospective advantage over Merck's Welireg, professionals point out

.With brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of professio...

Roche wagers up to $1B to increase Dyno gene treatment distribution treaty

.After developing a genetics treatment collaboration along with Dyno Therapeutics in 2020, Roche is ...